Sign in
CompletedNo phase

Developement of TipTraQ Home Sleep Test

Key facts

Who runs it
PranaQ Pte. Ltd.
Where
Taiwan1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
240 people enrolled
Started
1 Jun 2023
Ended
31 Dec 2023
Type of study
Observational
Record updated
22 October 2024

Who can take part

Age
20 years and older
Sex
Women and men
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 8 criteriaShow less

Who can take part

  • Subjects from the age of 20 and older that have an indication for an in-lab PSG study. The subject should be able to understand the study and sign the informed consent before being enrolled in the study. During the study period, the subject can withdraw from the study any time

Who cannot take part

  • Chronic opioid medication user Devastating Severe strokes, with the modified Rankin score (mRS)≥4
  • Subjects with the following medical conditions will be excluded from this study:
  • Heart transplant
  • Heart failure, New Youk Heart Association (NYHA) classification III or IV
  • Tracheostomy
  • Incapable of comprehending and signing the informed consent and questionnaires, including but not limited to subjects with severe Alzheimer's, unconscious by head trauma, or of someone with limited mental capacity
  • Cannot correctly follow the order to use the TipTraQ device

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The clinical study aims to develop and fine-tune the TipTraQ system, created by PranaQ, for home sleep apnea screening. The system comprises a wearable device and a cloud-based AI for estimating Total Sleep Time (TST) and Apnea-Hypopnea Index (AHI). This open-label, non-randomized study will recruit 240 subjects aged 20 and older from the Veteran General Hospital, Taipei.

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Development and Fine-tuning of a Medical-grade Wearable Device with Interpretable Artificial Intelligence System for the Obstructive Sleep Apnea-hypopnea Syndrome (OSAHS) Screening
Publications
Record updated
22 October 2024